Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-16 Purchase | 2023-11-16 4:37 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 20,000 | $2.46 | $49,200 | 527,114 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-27 4:11 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 1,470,588 | $3.4 | $4,999,999 | 4,326,435 (Indirect) | View |
| 2023-06-23 Purchase | 2023-06-26 4:42 pm | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 65,000 | $3.91 | $254,150 | 391,998 (Indirect Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:34 pm | DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO | 12,787 | $3.91 | $49,997 | 68,591 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:26 pm | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 12,787 | $3.91 | $49,997 | 29,943 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:21 pm | DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary | 10,000 | $3.91 | $39,100 | 32,290 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:14 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 38,364 | $3.91 | $150,003 | 507,114 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:03 pm | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 38,363 | $3.91 | $149,999 | 248,245 (Direct) | View |
| 2023-04-10 Purchase | 2023-04-11 5:40 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 468,750 | $1.6 | $750,000 | 608,750 (Direct) | View |
| 2022-12-08 Purchase | 2022-12-12 4:34 pm | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 57,079 | $1.4195 | $81,023 | 306,868 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-08 4:55 pm | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 24,874 | $1.3954 | $34,709 | 249,789 (Indirect Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 3:19 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) | View |
| 2022-12-02 Sale | 2022-12-06 3:19 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-23 4:23 pm | N/A 2034-01-21 | DiaMedica Therapeutics Inc. | DMAC | Lorianne Masuoka K. Chief Medical Officer | 285,000 | $0 | 285,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-02 5:05 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 9,375 | $2.8 | 39,318 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-02 5:00 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director | 14,285 | $2.8 | 14,285 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-02 4:47 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 30,357 | $2.8 | 278,602 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-02 4:39 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 21,428 | $2.8 | 59,937 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-02 4:30 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 19,196 | $2.8 | 411,194 (Direct) | View |
Ownership | 2023-06-27 4:10 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | STAHLBERG JAN TRILL AB 10% Owner | 0 | $0 | 4,021,608 (Indirect) | View |
| 2023-06-23 Gift | 2023-06-26 4:42 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 15,000 | $0 | 391,998 (Direct) | View |
Ownership | 2023-06-23 5:10 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | JACINTO RICHARD II 10% Owner | 0 | $0 | 4,558,823 (Indirect) | View |
| 2023-06-01 Option Award | 2023-06-02 5:16 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Daves Julie VanOrsdel SVP Clinical Development Oper. | 54,000 | $0 | 54,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 5:01 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer | 27,000 | $0 | 29,800 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:55 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Gruis Kirsten L Chief Medical Officer | 67,000 | $0 | 67,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:46 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary | 67,000 | $0 | 89,290 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:39 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO | 181,000 | $0 | 236,804 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:33 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 16,968 | $0 | 34,124 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:26 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 22,355 | $0 | 232,237 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:21 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director | 16,968 | $0 | 55,477 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:13 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 7,493 | $0 | 7,493 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:02 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 16,968 | $0 | 358,966 (Direct) | View |
| 2023-05-30 Option Award | 2023-05-30 6:18 pm | N/A 2033-05-29 | DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director | 32,320 | $0 | 32,320 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-11 5:40 pm | N/A 2033-04-09 | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 140,000 | $0 | 608,750 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-06 5:14 pm | N/A 2033-02-28 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 26,443 | $0 | 26,443 (Direct) | View |
Ownership | 2023-03-06 5:06 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 0 | $0 | 0 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 4:43 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director | 35,130 | $1.53 | 341,998 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 4:36 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 17,156 | $1.53 | 73,288 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 4:25 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director | 17,156 | $1.53 | 17,156 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 4:19 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director | 55,555 | $1.53 | 209,882 (Direct) | View |